fludeoxyglucose f18- fludeoxyglucose f-18 injection, solution
wisconsin medical radiopharmacy, llc - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f 18 injection is indicated for positron emission tomography (pet) imaging in the following settings: for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. for the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. none risk summary data from published case series and case reports describe fludeoxyglucose f 18 injection crossing the placenta with uptake by the fetus (see data ). all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose
lymph-flo
royal adelaide hospital radiopharmacy - antimony trisulfide -
mibitop 1 mg kit for radiopharmaceutical preparation
institute of isotopes co. ltd h-1121 budapest, konkoly-thege miklós út 29-33, hungary - tetrakis, methoxy isobutyl, isonitrile, copper, tetrafluorolborate - kit for radiopharmaceutical preparation powder for solution for injection - tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate 1 mg - diagnostic radiopharmaceuticals
joflupaan (123i) rotop 74 mbq/ml inj. sol. i.v. vial
rotop radiopharmacy gmbh - ioflupane (i-123) 74 mbq/ml - solution for injection - 74 mbq/ml - ioflupane (i-123) 74 mbq/ml - iodine ioflupane (123i)
joflupaan (123i) rotop 74 mbq/ml inj. sol. i.v. vial
rotop radiopharmacy gmbh - ioflupane (i-123) 74 mbq/ml - solution for injection - 74 mbq/ml - ioflupane (i-123) 74 mbq/ml - iodine ioflupane (123i)
ioflupan (123i) rotop 74 mbq/ml injektionslösung
rotop - dmsa- kit for the preparation of technetium tc99m succimer injection injection, powder, lyophilized, for solution
rotop pharmaka gmbh - 2,3-dimercaptosuccinic acid (unii: 4s9ju7xf01) (2,3-dimercaptosuccinic acid - unii:4s9ju7xf01) - 2,3-dimercaptosuccinic acid 1 mg - rotop - dmsa is a radiodiagnostic pharmaceutical. the kit contains the non-radioactive powder for reconstitution of the [99m tc]technetium succimer injection solution ([99m tc]-dmsa). the sodium [99m t]pertechnetat which is needed for the preparation is not part of this kit. after labelling with sodium [99m tc]technetium pertechnetat solution, rotop - dmsa is used for static renal scintigraphy when adequate diagnostics are not possible using other diagnostic procedures (such as ultrasound): - to identify focal renal parenchymal changes (e.g. in the case of renal infarction) - to identify norm variants such as atypical double kidney, small kidney, dysplastic kidney, horseshoe kidney, as well as to identify ectopic kidneys - to confirm absence of renal function in multicystic kidneys. take special care with rotop – dmsa rotop - dmsa is not suitable for determining global renal function from the dmsa accumulation. in the case of proximal tubulopathies [99m tc]dmsa does not lead to a sufficient diagnostic renal a
indium chloride
ge healthcare australia pty ltd - indium(111in) chloride -
atlantiscan solution
nova scotia health authority - fludeoxyglucose 18f - solution - 200mci - fludeoxyglucose 18f 200mci - diagnostic agents
amersham indium (111in) chloride 185mbq/0.5ml injection
ge healthcare australia pty ltd - indium (111in) chloride, quantity: 370 mbq/ml - injection, solution - excipient ingredients: hydrochloric acid - for the radiolabelling of approved polyaminocarboxylic acid derivatised monoclonal antibody preparations for in vivo diagnostic imaging procedures.